Blood Plasma Market Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Japan, India, China, Australia, Brazil, Mexico, Saudi Arabia, South Africa), Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2019 - 2025

Blood Plasma Market size is estimated to witness significant growth from 2018 to 2024.
 

Therapeutic protein drugs are essential medicines serving the patients in need of novel therapies. Recent technological advancements in therapeutic protein drug development have resulted in treatment of wide range of clinical indications such as hematology, genetic disorders, autoimmunity/inflammation and cancers. It is evident that the recent U.S. FDA approved plasma derived therapeutic proteins will serve large patient population augmenting the growth of blood plasma market in the upcoming future.
 

Increasing prevalence of liver diseases in elderly population globally will drive the growth of blood plasma market in the near future. The people suffering from end stage liver disease have complicated alterations and are mostly affected by hemostasis, with thrombocytopenia being more frequent. Frequent use of plasma in the patients with liver disease will result in increase in demand for blood plasma transfusions, boosting the industry growth in near future.
 

Lack of blood plasma transfusion services in the developing countries of Asia Pacific and Latin America region will be one of the major market impeding factor. The services in developing countries are fragmented, lack quality monitoring, have inadequate safety and are mostly dependent on paid donors. These prevailing factors in the developing countries will hamper the blood plasma market growth.
 

Hemorrhage is responsible for around 30%-40% of the trauma-related mortality. Increase in application of blood plasma in treatment of hemorrhage will boost the industry growth. According to the Brain Aneurysm Foundation, around 6 million people in the United States have unruptured brain aneurysm and require massive plasma transfusion in patients to prevent further injuries. Increase in use of plasma and platelets along with red blood cells (RBCs) to minimize the effects of hemorrhage will enhance the industry growth.
 

Distribution of blood plasma via ambulatory surgical centers is estimated to show substantial growth in upcoming years. Increase in number of people preferring ambulatory surgical centers for treatment of several complex diorders along with well equipped facilities to conduct proper blood plasma transfusion activities will boost the market growth.
 

U.S. blood plasma market is estimated to hold significant market share due to rise in number of people suffering from blood coagulation disorders, hemorrhage, hemostasis and other blood related diseases. The initiatives taken by the government and American Red Cross to create awareness regarding importance of blood donation along with rising prevalence of chronic diseases such as cancer and cardiovascular diseases will enhance the growth of blood plasma market growth in North America.
 

Germany blood plasma marker will witness lucrative growth in the forthcoming years as blood plasma transition is in high demand in the country. Increase in use of blood plasma derivatives in treatment of patients suffering from complex diseases such as cancer and hemorrhage will boost the demand for plasma, augmenting the business growth in Europe region. 
 

Some of the key industry players America’s Blood Centers, American Red Cross, American Association of Blood Banks, Blood Centers of America, Brazilian Red Cross, Canadian Red Cross, European Blood Alliance, French Red Cross, German Red Cross, Indian Red Cross, Italian Red Cross, Japanese Red Cross, Red Cross Society of China, Saudi Red Crescent Authority, South African Red Cross Society and Spanish Red Cross. The market players focus on market strategies such as merger acquisitions and innovative new product launches to expand their business across different geographical areas.
 

Blood Plasma Market by Application, 2013-2024 (USD Million)

• Coagulation factor deficiencies
• Thrombotic thrombocytopenic purpura
• Hemorrhage
• Liver disease
• Other plasma applications

Blood Plasma Market by Distribution Channel, 2013-2024 (USD Million)

• Hospitals
• Ambulatory Surgical Centers
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
• Latin America
  • Mexico
  • Brazil
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE

What Information does this report contain?